“Comprehensive Analysis of Factors Influencing Recurrence and Survival in Glioblastoma: Implications for Treatment Strategies”: A Single Center Study
Glioblastoma is a highly aggressive malignancy affecting the brain and central nervous system. It is the most common malignant primary brain tumor, yet its prognosis remains poor. Median survival typically ranges from around 13 months with standard treatment to up to 19.9 months in some recent clini...
Saved in:
| Main Authors: | Ahmed Bendari, Sunder Sham, Hamed Hammoud, Oana Vele, Brett Baskovich, David Huang, Alaa Bendari, Rachel Saks, Reham Al-Refai, Tasneem Bendari, Layth Kataw, Fnu Kiran, Fnu Anjali, Sanjay Kirshan Kumar, Manju Harshan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Journal of Molecular Pathology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-5261/5/4/35 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness
by: Maria Patrizia Mongiardi, et al.
Published: (2024-01-01) -
MicroRNAs - Biogênese, funções e características moleculares do glioblastoma
by: Felipe Amstalden Trevisan, et al.
Published: (2017-01-01) -
Features of epileptiform activity in patients with diagnosed glioblastoma: from genetic and biochemical mechanisms to clinical aspects
by: E. E. Tyagunova, et al.
Published: (2022-12-01) -
IDH mutation and MGMT methylation status in glioblastoma and other gliomas patients: a Russian retrospective cohort study
by: Moez Eid, et al.
Published: (2025-05-01) -
Gliosarcoma: A Very Rare Biphasic Histopathological Engima Associated with Very Poor Prognostic Parameters
by: Pal Ruchismita, et al.
Published: (2025-08-01)